In low-and middle-income countries (LMICs), inexpensive generic drugs like statins, ACE
inhibitors, and ARBs, especially if used in combination, might be the only practical way to …

The COVID-19 pandemic has disrupted life throughout the world. Newly developed vaccines
promise relief to people who live in high-income countries, although vaccines and …

Conclusion Taken together, although there is an urgent need for finding safe and available
options for treatment of COVID‐19 and its related fatal ARDS, we must balance our …

While most coronavirus disease 2019 (COVID-19) infections run a benign course with
recovery, the inexorable rise in case fatalities in several countries is grim testimony to the …

Objectives To assess the impact of adding statin (atorvastatin) and/or aspirin on clinical
deterioration in patients infected with SARS-CoV-2 who require hospitalisation. The safety of …

Scope Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
become pandemic, reaching almost one million death worldwide. At present standard …

Background Statins and aspirin have been proposed for treatment of COVID-19 because of
their anti-inflammatory and anti-thrombotic properties. Several observational studies have …

SARS-CoV-2 (COVID-19) has been changing the world since December 2019. A
comprehensive search into many COVID-19 treatment guidelines was conducted and …

ABSTRACT BACKGROUND The effectiveness of rosuvastatin plus colchicine,
emtricitabine/tenofovir, and of their combined use in hospitalized patients with coronavirus …

Background: Limited data on the efficacy and safety of currently applied COVID-19
therapeutics and their impact on COVID-19 outcomes have raised additional concern …